|
|
No.
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 |
Other Events.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Number
|
Description
|
|
Press Release, dated February 6, 2024
|
||
104
|
Interactive Data File (embedded within the Inline XBRL document)
|
Date: February 6, 2024
|
NUWELLIS, INC.
|
||
By:
|
/s/ Nestor Jaramillo, Jr
|
||
Name:
|
Nestor Jaramillo, Jr.
|
||
Title:
|
President and Chief Executive Officer
|
●
|
Six patients were able to receive physical therapy following treatment to help improve their mobility while in the ICU.
|
●
|
Five patients were transferred out of the ICU following treatment, three of whom were discharged from the hospital.
|
●
|
There were no catheter-related bloodstream infections or circuit complications attributed to aquapheresis access.
|
Document and Entity Information |
Feb. 06, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Feb. 06, 2024 |
Entity File Number | 001-35312 |
Entity Registrant Name | Nuwellis, Inc. |
Entity Central Index Key | 0001506492 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 68-0533453 |
Entity Address, Address Line One | 12988 Valley View Road |
Entity Address, City or Town | Eden Prairie |
Entity Address, State or Province | MN |
Entity Address, Postal Zip Code | 55344 |
City Area Code | 952 |
Local Phone Number | 345-4200 |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | NUWE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
-8?20$3;8T.P6BP^0"X99K>]9!:G
M
8+ :4W#C_?J0D
MVB)Y2"D5)>NF=7C>\_+K.9*L1'K[;KN.T%=,DY#$)X/)Z/4 X3@@BS!>G0PV
MR=!/@C ,LS7G97]+W*2E.N<7X \Q60I0(6BYCNKYOD-<
M@YB.ZV+5=5TK<,, O#'/VR:B^71V&ZTML;I(P$N+_I]-;[F#-C$H"57+<4)J
M&EAS/9?J:F"$FJE3:-P")\LRS(:H>,<48:\@A%@M+CAPADUQA$[F-)AE[)JB
M\Q",!$W?H3T@$A)4NFC/+V/E *; RI7DR(S;U2
MQE)UZ(K(>W][L6 E$2Z+WTI:\*S02JP:M8W!-3B[I=C>B1UI6Z[@FVF0+.H1
M[57[3%ZX'5 =&-+DHK!Z=U4A%W% Z".AV0#N4G;M?D8V[!SR?$86\*5TK0RI
M6BHR&M>,U=]MY=3IREX_U0ZBBB3E*Y1I$:&HT".>T(>"J@<$^:8=@XK+FBR7
M6(U^NBJT\S6FJS!>?:3D*7TX(^M'/X8O]JU*J; ,RL8%!?JZ+21;%_8",F>*
MPA$*E$M0H>E#K=CWEKQH$Z#: )/DFK#X=E4+IXL%8S I_KL,8SP!*\&BD^H
MU#6N L#5;0V8.[!7@"E/\%\$7HD/B$O0==R+LX5M3\D+EA^B'TB1V3=Z'HY\
MKR;Y7DWRO5;(]]HFW_M&\KT:Y-\_D7Z2[]4EWWLY^5X5^=ZAR9_6)']:D_QI
M*^1/VR9_^HWD3^N0SS:LIT?]:5WVIR]G?UK%_O0@[)^QC]?TGCS%-O)U%<1]
M6>6*^KUG*\QK]K6(5[(TWGF[+$O"@+R3.COBY83N'>\F[WK&^E*(?Z/-@C_!6=PP\
MP.LK;#NZ%[=VP4-[V:EC?&](DOK1W^&C\;<"-B&$LB)T!;1DVPK64 ^UX-83
M-<1S"6*:WMS
<7/:K#=M^E,VWIV'-R08RWU$<4';[1?;JYYUJ
MQDB;S8?E934%.^:YH 2^O-."& 0J"WS%,
M!" XO6;B2'M8G6''@?RV@:%T[M%H_T;IVW/6%3K3FRO.8'$.KO-K,LB"BF(NJ
MAVQ
]&@
MMU1]>'3M.48@*<48( ]O]]B;_T/)Q,7_._9.6WUMU0'B@QD_QDP5'%X53*C;
M]>CQ:%M6V._M[QK<70KO_$6"YO?ZM\-U^I,2_$OUES/^'U!+ 0(4 Q0 (
M .U(1E@O0UP+2P, $D/ 1 " 0 !N=7=E+3(P,C0P
M,C V+GAS9%!+ 0(4 Q0 ( .U(1EB-!,],@ @ '58 5
M " 7H# !N=7=E+3(P,C0P,C V7VQA8BYX;6Q02P$"% ,4 " #M2$98
MU"F^Y^$% #\/@ %0 @ $M# ;G5W92TR,#(T,#(P-E]P
M